2026-06-05T13:12:11Zhttps://riuma.uma.es/rest/oai/request

oai:riuma.uma.es:10630/313382026-02-03T11:12:51Zcom_10630_2254col_10630_37953

00925njm 22002777a 4500 dc Chicharro-Luna, Esther author Gracia-Vesga, Miguel Ángel author Ramos Petersen, Laura author Gijón-Noguerón, Gabriel author 2024 Progressive systemic sclerosis or systemic scleroderma (SS) is a chronic and rare autoimmune disease that mainly affects the skin and various internal organs. Raynaud's phenomenon and digital ulcers are some of the symptoms that affect the foot, causing a decrease in the quality of life of patients. The objective of this study is to determine the functionality of the feet in patients with SS and determine the impact on their daily lives. SS is a disease that affects foot functionality in patients, with a greater impact on the pain scale. There is a correlation between the final FFI score and the final SySQ score, so improving foot functionality could help to improve the overall functionality of the patient with sclerosis. Esther Chicharro-Luna, Miguel Ángel Gracia-Vesga, Laura Ramos-Petersen, Gabriel Gijón-Nogueron, Impact of foot functionality in patients with systemic sclerosis: Cross-sectional study, Journal of Tissue Viability, Volume 33, Issue 2, 2024, Pages 202-207, ISSN 0965-206X, https://doi.org/10.1016/j.jtv.2024.03.004. https://hdl.handle.net/10630/31338 https://doi.org/10.1016/j.jtv.2024.03.004 Esclerodermia sistémica Pies - Lesiones y heridas Impact of foot functionality in patients with systemic sclerosis: Cross-sectional study